Financial Performance

Pacer ETFs slashes fees and expands its Swan SOS series, intensifying competition in the $92 billion buffer ETF market for risk-conscious investors.

New data reveals upstream patient guidance slashes surgical costs, challenging the old guard of healthcare management and signaling a new era of digital-first care.

Crypto exchange BingX just airdropped SpaceX 'tokens' to millions. It's a glimpse into a future of democratized investing, but the risks are very real.

A small Ohio company's new device aims to solve the hotel industry's biggest tech problem, challenging giants and reshaping the economics of guest loyalty.

Germany's 7-1 World Cup opener shatters TV records with over 23M viewers, ignited by BVB stars. A look at the renewed national pride and advertising goldmine.

Vendors hold the cards in IT renewals. A new platform aims to change that by arming enterprises with pre-quote intelligence to secure better deals.

New data reveals elevated cortisol in over 75% of hard-to-treat diabetes patients, paving the way for a novel drug to tackle treatment resistance.

A single AML patient's journey to a stem cell transplant after treatment with CER-1236 offers a glimmer of hope, but is it a breakthrough or a mirage?

Clip Money extends its debt runway, but a split among investors reveals a deeper story. Is this a savvy move to fuel expansion or a necessary patch on a leaky hull?

Kaltura’s latest awards reveal a major shift as giants like IBM and McDonald's ditch one-way messages for AI-driven conversations that anticipate user needs.

Legend Biotech's stunning trial results for an 'in vivo' CAR-T therapy could make advanced cancer treatment faster, safer, and accessible to all.

Phase 1 data for Marea Therapeutics’ MAR002 suggests a potential new era for acromegaly treatment, promising better control with far fewer injections.

In an era of AI defense, Bank of America is betting on 2,500 in-person 'Scaminars.' A strategic look at why the future of fraud fighting is surprisingly human.

While CEO Craig Chambliss's EY award makes headlines, the real story is Neurelis's disruption of epilepsy care and its ambitious pipeline for brain disorders.

Iowa State University honors a key partner for securing its finances, revealing the critical, often invisible, tech that builds trust in public institutions.

Alexandria Real Estate's top WSJ ranking for talent readiness reveals a new playbook where human capital is the most valuable asset, even in real estate.

New drill results, including 100 metres of 1.00 g/t gold, and a fully funded feasibility study are repositioning the Spanish Mountain project's economics.

A world-first treatment in Canada saved a young burn victim's face, bypassing devastating grafts. But can this 'miracle' therapy move from one-off to standard care?

With its Calcatreu mine now in production, Patagonia Gold hires a 40-year veteran to systematically unlock the value of its 375 Argentine properties.

Flagstar Bank is ditching the 'buy' model, building its own platform and a patent-pending AI. Is this the future of banking or a costly, high-stakes gamble?